Advance Access & Delivery
  • Home
  • Reports Our Team Resources News
  • Overview of Programs Zero TB Harm Reduction US-Mexico Border Initiative
  • Access to Medicines
  • Donate Search-Treat-Prevent Approach Work with AA&D
  • Contact AA&D
Advance Access & Delivery
  • Home/
  • About AA&D/
    • Reports
    • Our Team
    • Resources
    • News
  • Delivery of Care/
    • Overview of Programs
    • Zero TB
    • Harm Reduction
    • US-Mexico Border Initiative
  • Access to Medicines/
    • Access to Medicines
  • Get involved/
    • Donate
    • Search-Treat-Prevent Approach
    • Work with AA&D
  • Contact AA&D/
Advance Access & Delivery

News

Advance Access & Delivery
  • Home/
  • About AA&D/
    • Reports
    • Our Team
    • Resources
    • News
  • Delivery of Care/
    • Overview of Programs
    • Zero TB
    • Harm Reduction
    • US-Mexico Border Initiative
  • Access to Medicines/
    • Access to Medicines
  • Get involved/
    • Donate
    • Search-Treat-Prevent Approach
    • Work with AA&D
  • Contact AA&D/
October 20, 2017

Investigators release interim results on clinical trial studying MDR-TB treatment regimen

October 20, 2017/ AA&D Media
 
rifampin.jpg

Partners In Health, Interactive Research and Development and the Zero TB Initiative welcome the release of interim results from STREAM Stage 1 clinical trial, which was conducted to study a new treatment regimen for multidrug-resistant tuberculosis (MDR-TB).

Read more

October 20, 2017/ AA&D Media/ 1 Comment

AA&D Media

  • Bangladesh Health Minister signs ...
  • AA&D report highlights pioneering ...

Contact

Send us an email

Donate

Help support our work
 

Learn

Learn more about our work
View our Privacy Policy
View our Terms and Conditions

By striving to do the impossible, man has always achieved what is possible. - MBakunin

© · Advance Access & Delivery